Generics price fixing charges land pharma firms $447.2m penalty

Generics price fixing charges land pharma firms $447.2m penalty According to the US Department of Justice (DOJ), three companies—Taro Pharmaceuticals, Sandoz, and Apotex—have agreed to fork over a total of $447.2m USD to settle their alleged violations of the False Claims Act. According to the government’s allegations, the firms conspired to fix the prices of various generic drugs, resulting in higher prices paid by federal health care programs and beneficiaries.

Read the source article at outsourcing-pharma.com
2021-10-05 17:39:00